Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer ( HOT1401 / NJLCG1401 )-Reference-Cited by-同舟云学术

Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer ( HOT1401 / NJLCG1401 )

Published:2021-06-02 Issue:14 Volume:12 Page:2113-2121
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Tanaka Hisashi¹^ORCID,Hasegawa Yukihiro²,Fujita Yuka³,Nakamura Atsushi⁴,Kikuchi Eiki⁵,Kawai Yasutaka⁶,Harada Toshiyuki⁷,Watanabe Naomi⁸,Yokouchi Hiroshi⁹¹⁰,Usui Kazuhiro¹¹,Saito Ryota¹²,Watanabe Hiroshi¹³,Masuda Tomomi¹⁴,Fukuhara Tatsuro¹⁵,Kudo Keita¹⁶,Honda Ryoichi¹⁷,Oizimi Satoshi⁵¹⁰,Maemondo Makoto¹⁸,Inoue Akira¹⁹,Morikawa Naoto¹⁸¹⁹

Affiliation:

1. Department of Respiratory Medicine Hirosaki University Graduate School of Medicine Hirosaki Japan

2. Department of Respiratory Medicine Aomori Prefectural Central Hospital Aomori Japan

3. Department of Respiratory Medicine National Hospital Organization Asahikawa Medical Center Asahikawa Japan

4. Department of Pulmonary Medicine Sendai Kousei Hospital Sendai Japan

5. First Department of Medicine Hokkaido University Hospital Sapporo Japan

6. Department of Respiratory Medicine Oji General Hospital Tomakomai Japan

7. Department of Respiratory Medicine JCHO Hokkaido Hospital Sapporo Japan

8. Department of Respiratory Medicine Sunagawa City Medical Center Sunagawa Japan

9. Department of Pulmonary Medicine Fukushima Medical University School of Medicine Fukushima Japan

10. Department of Respiratory Medicine National Hospital Organization Hokkaido Cancer Center Sapporo Japan

11. Division of Respirology NTT Medical Center Tokyo Tokyo Japan

12. Department of Respiratory Medicine Tohoku University School of Medicine Sendai Japan

13. Department of Respiratory Medicine Saka General Hospital Shiogama Japan

14. Department of Respiratory Medicine Gunma University Maebashi Japan

15. Department of Respiratory Medicine Miyagi Cancer Center Natori Japan

16. Department of Medical Oncology and Respiratory Medicine National Hospital Organization Osaka Minami Medical Center Osaka Japan

17. Department of Respiratory Medicine Asahi General Hospital Chiba Japan

18. Division of Pulmonary Medicine, Allergy, and Rheumatology Iwate Medical University Faculty of Medicine Graduate School of Medicine Morioka Iwate Japan

19. Department of Palliative Medicine Tohoku University School of Medicine Sendai Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14048

Reference24 articles.

1. Cancer statistics, 2017

2. Bronchopulmonary neuroendocrine tumors

3. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline

4. Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society;Haigan;2023-06-20

2. Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review;Clinical Lung Cancer;2023-05

3. Efficacy and safety of anlotinib as maintenance therapy after induction chemotherapy in extensive-stage small-cell lung cancer;Anti-Cancer Drugs;2022-12-23

4. Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society;JTO Clinical and Research Reports;2022-05